Central Nervous System Prophylaxis and Treatment in Acute Leukemias

In addition to treatment with CNS-penetrant systemic therapy, intrathecal prophylaxis is indicated in all patients with acute lymphoblastic leukemia, however is not uniformly administered in patients with AML without high-risk features.